Henry Schein Company Profile (NASDAQ:HSIC)

About Henry Schein (NASDAQ:HSIC)

Henry Schein logoHenry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics. The Company provides its services to dental practitioners and laboratories, animal health clinics and physician practices, as well as government and institutional healthcare clinics.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment Wholesale
  • Sub-Industry: Health Care Distributors
  • Symbol: NASDAQ:HSIC
  • CUSIP: 80640710
  • Web: www.henryschein.com
Capitalization:
  • Market Cap: $14.66 billion
  • Outstanding Shares: 79,329,000
Average Prices:
  • 50 Day Moving Avg: $183.72
  • 200 Day Moving Avg: $173.35
  • 52 Week Range: $146.23 - $186.99
P/E:
  • Trailing P/E Ratio: 28.03
  • Foreward P/E Ratio: 22.92
  • P/E Growth: 2.50
Sales & Book Value:
  • Annual Revenue: $11.78 billion
  • Price / Sales: 1.24
  • Book Value: $35.07 per share
  • Price / Book: 5.27
Profitability:
  • EBIDTA: $1 billion
  • Net Margins: 4.53%
  • Return on Equity: 19.74%
  • Return on Assets: 8.42%
Debt:
  • Debt-to-Equity Ratio: 0.25%
  • Current Ratio: 1.48%
  • Quick Ratio: 0.77%
Misc:
  • Average Volume: 358,536 shs.
  • Beta: 1.09
  • Short Ratio: 3.93
 
Frequently Asked Questions for Henry Schein (NASDAQ:HSIC)

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) issued its earnings results on Tuesday, May, 9th. The company reported $1.76 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.65 by $0.11. The company earned $2.92 billion during the quarter, compared to the consensus estimate of $2.83 billion. Henry Schein had a return on equity of 19.74% and a net margin of 4.53%. The firm's revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period last year, the business posted $1.41 EPS. View Henry Schein's Earnings History.

What guidance has Henry Schein issued on next quarter's earnings?

Henry Schein updated its FY17 earnings guidance on Tuesday, May, 9th. The company provided earnings per share (EPS) guidance of $7.17-7.30 for the period, compared to the Thomson Reuters consensus estimate of $7.25.

Where is Henry Schein's stock going? Where will Henry Schein's stock price be in 2017?

15 brokerages have issued 1 year target prices for Henry Schein's stock. Their forecasts range from $160.00 to $208.00. On average, they anticipate Henry Schein's stock price to reach $181.46 in the next twelve months. View Analyst Ratings for Henry Schein.

What are analysts saying about Henry Schein stock?

Here are some recent quotes from research analysts about Henry Schein stock:

  • 1. According to Zacks Investment Research, "In the past three months, Henry Schein has consistently outperformed the S&P 500 Market at large with respect to share price movement. Apart from balanced segmental growth across all its operating segments, the company’s share gains in both the U.S. and overseas markets raise optimism. Management is also upbeat about several strategic tie ups made during the reported quarter. We are also positive about Henry Schein’s buyout of Marrodent and SAS which have the potential to capture the bountiful dental market opportunities. On the flip side despite a strong quarterly show last time, the company’s unchanged EPS guidance for 2017 is uninspiring. Meanwhile, Henry Schein’s venture in digital dentistry through Dentsply Sirona deal may intensify its already weak operating margin scenario on escalating education and training expenses. Also, foreign currency fluctuations continued to mar the company’s financials." (6/23/2017)
  • 2. Evercore ISI analysts commented, "HSIC continues to deliver consistent HSD to LDD EPS growth despite an operating environment that has been somewhat mixed, albeit North American Dental continues to show signs of recovery. With the acquisition engine still churning and an elevated level of buybacks, management has been able to deliver the type of TSR expected and thus the valuation remains notably elevated on an absolute basis (less so on a relative basis). While we also value consistency and predictability, we acknowledge we missed the November entry point (fears of US slowdown) and thus at current levels see risk / reward as more fully balanced (particularly with extra week headwind in 2017 + unfavorable Fx environment). Given this dynamic we reiterate our Hold rating and argue shares are now accurately pricing in the current operating environment. Thus we await another period of uncertainty prior to revisiting our long-term constructive view on shares." (2/21/2017)

Who are some of Henry Schein's key competitors?

Who are Henry Schein's key executives?

Henry Schein's management team includes the folowing people:

  • Stanley M. Bergman, Chairman of the Board, Chief Executive Officer
  • James P. Breslawski CPA, President, Director; Chief Executive Officer of Henry Schein Global Dental Group
  • Steven Paladino CPA, Chief Financial Officer, Executive Vice President, Director
  • Peter McCarthy, President of Global Animal Health Group
  • David C. McKinley, President of Corporate Commercial Development Group, Chief Commercial Officer
  • Bob Minowitz, President, International Dental Group, EMEA Region
  • Bridget A. Ross, President of Global Medical Group
  • Gerald A. Benjamin, Chief Administrative Officer, Executive Vice President, Director
  • Mark E. Mlotek, Chief Strategic Officer, Executive Vice President, Director
  • Karen N. Prange, Executive Vice President; Chief Executive Officer of Global Animal Health, Medical and Dental Surgical Group

Who owns Henry Schein stock?

Henry Schein's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Alecta Pensionsforsakring Omsesidigt (3.16%), Swedbank (1.61%), Congress Asset Management Co. MA (0.55%), Fisher Asset Management LLC (0.53%), Acadian Asset Management LLC (0.42%) and Chevy Chase Trust Holdings Inc. (0.34%). Company insiders that own Henry Schein stock include Barry J Alperin, David Mckinley, Donald J Kabat, Gerald A Benjamin, James A Harding, Kurt P Kuehn, Lonnie Shoff, Lorelei Mcglynn, Louis W Sullivan, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Norman S Matthews, Paul Brons, Paul Rose, Peter M Mccarthy, Philip A Laskawy, Robert Minowitz, Stanley Komaroff, Stanley M Bergman and Steven Paladino. View Institutional Ownership Trends for Henry Schein.

Who sold Henry Schein stock? Who is selling Henry Schein stock?

Henry Schein's stock was sold by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Vontobel Asset Management Inc., Fisher Asset Management LLC, State of Alaska Department of Revenue, Acadian Asset Management LLC, Neville Rodie & Shaw Inc., Fox Run Management L.L.C. and Chevy Chase Trust Holdings Inc.. Company insiders that have sold Henry Schein stock in the last year include Donald J Kabat, Gerald A Benjamin, James A Harding, Lorelei Mcglynn, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Paul Brons, Paul Rose, Philip A Laskawy and Steven Paladino. View Insider Buying and Selling for Henry Schein.

Who bought Henry Schein stock? Who is buying Henry Schein stock?

Henry Schein's stock was acquired by a variety of institutional investors in the last quarter, including PGGM Investments, AMI Asset Management Corp, Congress Asset Management Co. MA, Riverbridge Partners LLC, Swedbank, Hartford Investment Management Co., Mn Services Vermogensbeheer B.V. and Bank of Montreal Can. View Insider Buying and Selling for Henry Schein.

How do I buy Henry Schein stock?

Shares of Henry Schein can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Henry Schein's stock price today?

One share of Henry Schein stock can currently be purchased for approximately $184.74.


MarketBeat Community Rating for Henry Schein (NASDAQ HSIC)
Community Ranking:  1.5 out of 5 ( )
Outperform Votes:  109 (Vote Outperform)
Underperform Votes:  253 (Vote Underperform)
Total Votes:  362
MarketBeat's community ratings are surveys of what our community members think about Henry Schein and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Henry Schein (NASDAQ:HSIC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 10 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $181.46 (1.77% downside)

Analysts' Ratings History for Henry Schein (NASDAQ:HSIC)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/21/2017Jefferies Group LLCReiterated RatingHold$177.00LowView Rating Details
7/13/2017Credit Suisse GroupReiterated RatingHold$160.00 -> $160.00LowView Rating Details
7/6/2017Stifel NicolausReiterated RatingHoldLowView Rating Details
6/12/2017Piper Jaffray CompaniesInitiated CoverageNeutral -> Neutral$200.00LowView Rating Details
5/10/2017Barrington ResearchBoost Price TargetOutperform -> Outperform$196.00 -> $198.00LowView Rating Details
4/11/2017Craig HallumInitiated CoverageHoldLowView Rating Details
3/15/2017Deutsche Bank AGInitiated CoverageHold -> Hold$174.00LowView Rating Details
2/22/2017Leerink SwannSet Price TargetHold$183.00N/AView Rating Details
2/21/2017Evercore ISIBoost Price TargetHold$160.00 -> $178.00N/AView Rating Details
1/10/2017GabelliUpgradeHold -> Buy$208.00N/AView Rating Details
1/3/2017Robert W. BairdUpgradeNeutral -> Outperform$164.00 -> $170.00N/AView Rating Details
12/6/2016Northcoast ResearchDowngradeBuy -> NeutralN/AView Rating Details
11/3/2016J P Morgan Chase & CoReiterated RatingHold$163.00N/AView Rating Details
10/11/2016Goldman Sachs Group, Inc. (The)UpgradeNeutral -> Buy$185.00N/AView Rating Details
9/12/2016Bank of America CorporationInitiated CoverageBuy$185.00N/AView Rating Details
11/5/2015Royal Bank Of CanadaBoost Price TargetOutperform$165.00 -> $170.00N/AView Rating Details
7/30/2015Evercore Partners IncReiterated RatingBuy -> HoldN/AView Rating Details
(Data available from 7/26/2015 forward)

Earnings

Earnings History for Henry Schein (NASDAQ:HSIC)
Earnings by Quarter for Henry Schein (NASDAQ:HSIC)
Earnings History by Quarter for Henry Schein (NASDAQ HSIC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017Q1 17$1.65$1.76$2.83 billion$2.92 billionViewListenView Earnings Details
2/21/2017Q416$1.85$1.88$3.08 billion$3.12 billionViewListenView Earnings Details
11/2/2016Q316$1.65$1.68$2.88 billion$2.87 billionViewN/AView Earnings Details
8/4/2016Q216$1.63$1.64$2.85 billion$2.87 billionViewN/AView Earnings Details
5/3/2016Q116$1.39$1.41$2.66 billion$2.70 billionViewListenView Earnings Details
2/10/2016Q415$1.65$1.67$2.82 billion$2.90 billionViewListenView Earnings Details
11/4/2015Q315$1.47$1.55$2.70 billion$2.70 billionViewListenView Earnings Details
7/29/2015Q215$1.46$1.46$2.68 billion$2.60 billionViewListenView Earnings Details
5/4/2015Q1$1.27$1.28$2.54 billion$25.00 billionViewListenView Earnings Details
2/11/2015Q414$1.51$1.56$2.72 billion$2.70 billionViewListenView Earnings Details
11/6/2014Q314$1.31$1.34$2.55 billion$2.62 billionViewListenView Earnings Details
8/4/2014Q214$1.33$1.35$2.56 billion$2.60 billionViewListenView Earnings Details
5/6/2014Q1$1.13$1.18$2.43 billion$2.40 billionViewListenView Earnings Details
2/11/2014Q413$1.39$1.43$2.53 billion$2.50 billionViewListenView Earnings Details
11/5/2013Q313$1.21$1.22$2.37 billion$2.30 billionViewListenView Earnings Details
8/6/2013Q2 2013$1.23$1.23$2.39 billion$2.40 billionViewListenView Earnings Details
5/7/2013Q1 2013$1.07$1.06$2.25 billion$2.30 billionViewListenView Earnings Details
2/13/2013Q4 2012$1.21$1.26$2.40 billion$2.40 billionViewListenView Earnings Details
11/7/2012Q312$1.07$1.08$2.24 billion$2.23 billionViewN/AView Earnings Details
8/2/2012$1.10$1.11ViewN/AView Earnings Details
5/8/2012$0.92$0.98ViewN/AView Earnings Details
2/15/2012$1.12$1.15ViewN/AView Earnings Details
11/1/2011$1.00$0.99ViewN/AView Earnings Details
8/2/2011$1.00$1.01ViewN/AView Earnings Details
5/3/2011$0.80$0.82ViewN/AView Earnings Details
2/22/2011$0.96$1.00ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Henry Schein (NASDAQ:HSIC)
2017 EPS Consensus Estimate: $7.16
2018 EPS Consensus Estimate: $8.05
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$1.60$1.67$1.64
Q2 20175$1.71$1.75$1.73
Q3 20175$1.76$1.84$1.79
Q4 20175$1.94$2.03$2.00
Q1 20183$1.90$1.93$1.92
Q2 20183$1.93$1.96$1.95
Q3 20183$1.96$2.02$2.00
Q4 20183$2.12$2.27$2.19
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Henry Schein (NASDAQ:HSIC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Henry Schein (NASDAQ:HSIC)
Insider Ownership Percentage: 1.27%
Institutional Ownership Percentage: 90.62%
Insider Trades by Quarter for Henry Schein (NASDAQ:HSIC)
Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)
Insider Trades by Quarter for Henry Schein (NASDAQ:HSIC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/11/2017Gerald A BenjaminEVPSell12,578$175.10$2,202,407.80View SEC Filing  
3/23/2017Lorelei McglynnSVPSell9,300$171.76$1,597,368.00View SEC Filing  
3/20/2017Michael RacioppiSVPSell9,969$171.69$1,711,577.61View SEC Filing  
3/17/2017Mark E MlotekEVPSell5,559$170.98$950,477.82View SEC Filing  
3/8/2017James A HardingSVPSell10,552$171.60$1,810,723.20View SEC Filing  
3/8/2017Philip A LaskawyDirectorSell1,103$171.51$189,175.53View SEC Filing  
3/2/2017Michael S EttingerSVPSell6,960$171.09$1,190,786.40View SEC Filing  
2/27/2017Donald J KabatDirectorSell4,334$173.62$752,469.08View SEC Filing  
2/22/2017Paul RoseSVPSell6,821$173.24$1,181,670.04View SEC Filing  
2/22/2017Steven PaladinoCFOSell13,072$173.40$2,266,684.80View SEC Filing  
12/12/2016Kurt P KuehnDirectorBuy1,000$151.41$151,410.00View SEC Filing  
11/3/2016Mark E MlotekEVPSell2,417$155.19$375,094.23View SEC Filing  
8/29/2016Paul BronsDirectorSell3,381$164.03$554,585.43View SEC Filing  
6/2/2016Gerald A BenjaminEVPSell9,991$175.08$1,749,224.28View SEC Filing  
5/16/2016James A HardingSVPSell10,302$172.60$1,778,125.20View SEC Filing  
5/12/2016Peter M MccarthyInsiderSell1,158$171.75$198,886.50View SEC Filing  
3/15/2016Lonnie ShoffCEOSell3,028$168.29$509,582.12View SEC Filing  
3/14/2016David MckinleyInsiderSell3,339$167.92$560,684.88View SEC Filing  
3/14/2016Norman S MatthewsDirectorSell5,335$167.75$894,946.25View SEC Filing  
3/10/2016Donald J KabatDirectorSell1,218$168.38$205,086.84View SEC Filing  
3/7/2016Barry J AlperinDirectorSell1,635$167.36$273,633.60View SEC Filing  
3/7/2016Michael S EttingerSVPSell5,423$168.13$911,768.99View SEC Filing  
3/4/2016Philip A LaskawyDirectorSell1,317$166.88$219,780.96View SEC Filing  
3/2/2016Louis W SullivanDirectorSell11,735$168.59$1,978,403.65View SEC Filing  
3/2/2016Mark E MlotekEVPSell4,982$167.93$836,627.26View SEC Filing  
2/26/2016Barry J AlperinDirectorSell7,540$167.96$1,266,418.40View SEC Filing  
2/24/2016Robert MinowitzInsiderSell9,648$165.48$1,596,551.04View SEC Filing  
2/22/2016Michael RacioppiSVPSell21,567$166.74$3,596,081.58View SEC Filing  
2/17/2016Stanley KomaroffInsiderSell8,000$163.53$1,308,240.00View SEC Filing  
2/16/2016Norman S MatthewsDirectorSell4,230$160.05$677,011.50View SEC Filing  
2/12/2016Steven PaladinoCFOSell11,727$157.21$1,843,601.67View SEC Filing  
2/11/2016Donald J. KabatDirectorSell6,637$156.36$1,037,761.32View SEC Filing  
12/17/2015Michael RacioppiSVPSell9,901$155.92$1,543,763.92View SEC Filing  
12/10/2015Stanley M. BergmanCEOSell61,800$155.45$9,606,810.00View SEC Filing  
11/9/2015Paul RoseSVPSell3,638$151.92$552,684.96View SEC Filing  
11/5/2015Mark E. MlotekEVPSell2,952$155.00$457,560.00View SEC Filing  
11/5/2015Stanley KomaroffInsiderSell6,297$154.89$975,342.33View SEC Filing  
9/16/2015Philip A LaskawyDirectorSell4,000$136.20$544,800.00View SEC Filing  
5/6/2015Paul BronsDirectorSell3,801$136.70$519,596.70View SEC Filing  
3/19/2015Michael S EttingerSVPSell4,352$139.75$608,192.00View SEC Filing  
3/18/2015James P BreslawskiCEOSell12,811$139.45$1,786,493.95View SEC Filing  
3/17/2015Leonard A DavidSVPSell3,935$140.00$550,900.00View SEC Filing  
3/16/2015Paul RoseSVPSell3,264$140.13$457,384.32View SEC Filing  
3/13/2015Norman S MatthewsDirectorSell9,200$136.07$1,251,844.00View SEC Filing  
3/11/2015Philip A LaskawyDirectorSell2,669$136.60$364,585.40View SEC Filing  
3/10/2015Donald J KabatDirectorSell2,002$138.00$276,276.00View SEC Filing  
3/5/2015Barry J AlperinDirectorSell6,637$140.64$933,427.68View SEC Filing  
2/24/2015Stanley KomaroffInsiderSell8,000$141.69$1,133,520.00View SEC Filing  
2/12/2015Donald J KabatDirectorSell5,000$142.68$713,400.00View SEC Filing  
2/12/2015Gerald A BenjaminEVPSell22,116$142.71$3,156,174.36View SEC Filing  
2/12/2015Robert MinowitzInsiderSell11,254$142.63$1,605,158.02View SEC Filing  
12/18/2014Leonard A DavidSVPSell3,557$135.34$481,404.38View SEC Filing  
12/9/2014Stanley M BergmanCEOSell69,600$135.56$9,434,976.00View SEC Filing  
12/8/2014Stanley M BergmanCEOSell23,485$136.34$3,201,944.90View SEC Filing  
11/24/2014Stanley KomaroffInsiderSell13,757$133.06$1,830,506.42View SEC Filing  
11/7/2014Lorelei McglynnSVPSell15,746$129.03$2,031,706.38View SEC Filing  
11/7/2014Mark E MlotekEVPSell6,262$128.75$806,232.50View SEC Filing  
9/2/2014Philip A LaskawyDirectorSell15,438$119.40$1,843,297.20View SEC Filing  
8/29/2014Louis W SullivanDirectorSell17,262$119.99$2,071,267.38View SEC Filing  
6/9/2014Barry J AlperinDirectorSell7,500$120.39$902,925.00View SEC Filing  
6/2/2014Gerald A BenjaminEVPSell12,354$119.50$1,476,303.00View SEC Filing  
5/28/2014Norman S MatthewsDirectorSell6,637$118.68$787,679.16View SEC Filing  
5/19/2014Donald KabatDirectorSell5,000$116.30$581,500.00View SEC Filing  
5/15/2014Paul BronsDirectorSell5,363$113.77$610,148.51View SEC Filing  
3/19/2014Barry AlperinDirectorSell7,500$119.18$893,850.00View SEC Filing  
3/17/2014Lonnie ShoffCEOSell3,722$119.06$443,141.32View SEC Filing  
3/12/2014Michael EttingerSVPSell3,537$119.20$421,610.40View SEC Filing  
3/11/2014David MckinleyInsiderSell2,387$119.65$285,604.55View SEC Filing  
3/11/2014James BreslawskiCEOSell72,642$119.35$8,669,822.70View SEC Filing  
3/11/2014Paul RoseSVPSell3,783$119.72$452,900.76View SEC Filing  
3/10/2014Robert MinowitzInsiderSell11,553$119.98$1,386,128.94View SEC Filing  
3/4/2014Donald KabatDirectorSell5,000$119.15$595,750.00View SEC Filing  
2/28/2014Michael RacioppiSVPSell18,614$118.91$2,213,390.74View SEC Filing  
2/26/2014Stanley KomaroffInsiderSell18,000$119.36$2,148,480.00View SEC Filing  
2/25/2014Mark MlotekEVPSell20,333$119.16$2,422,880.28View SEC Filing  
2/20/2014Steven PaladinoCFOSell28,757$117.79$3,387,287.03View SEC Filing  
2/12/2014Philip LaskawyDirectorSell5,851$114.91$672,338.41View SEC Filing  
12/19/2013Mark MlotekEVPSell22,004$111.97$2,463,787.88View SEC Filing  
12/19/2013Michael RacioppiSVPSell29,257$111.97$3,275,906.29View SEC Filing  
12/17/2013Gerald BenjaminEVPSell41,664$111.66$4,652,202.24View SEC Filing  
12/17/2013James BreslawskiCEOSell57,754$111.91$6,463,250.14View SEC Filing  
12/16/2013Steven PaladinoCFOSell47,652$112.31$5,351,796.12View SEC Filing  
12/13/2013Stanley BergmanCEOSell78,000$111.90$8,728,200.00View SEC Filing  
12/6/2013Leonard DavidSVPSell13,968$113.14$1,580,339.52View SEC Filing  
11/26/2013Stanley KomaroffInsiderSell22,329$114.79$2,563,145.91View SEC Filing  
8/23/2013Philip LaskawyDirectorSell21,637$103.17$2,232,289.29View SEC Filing  
8/22/2013Norman MatthewsDirectorSell9,851$103.95$1,024,011.45View SEC Filing  
8/20/2013Louis SullivanDirectorSell15,000$103.91$1,558,650.00View SEC Filing  
8/12/2013Donald KabatDirectorSell2,500$106.25$265,625.00View SEC Filing  
6/18/2013Barry J AlperinDirectorSell7,500$97.74$733,050.00View SEC Filing  
5/8/2013James A HardingCTOSell12,000$92.64$1,111,680.00View SEC Filing  
3/8/2013Donald J KabatDirectorSell4,038$90.00$363,420.00View SEC Filing  
12/4/2012Donald J KabatDirectorSell15,000$80.04$1,200,600.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Henry Schein (NASDAQ:HSIC)
Latest Headlines for Henry Schein (NASDAQ:HSIC)
Source:
DateHeadline
finance.yahoo.com logoHenry Schein To Webcast Second Quarter 2017 Conference Call On Tuesday, August 8, 2017 At 10:00 A.M. ET
finance.yahoo.com - July 25 at 7:55 PM
finance.yahoo.com logoCan Henry Schein (HSIC) Spring a Surprise in Q2 Earnings?
finance.yahoo.com - July 24 at 11:07 PM
finance.yahoo.com logoETFs with exposure to Henry Schein, Inc. : July 24, 2017
finance.yahoo.com - July 24 at 11:07 PM
americanbankingnews.com logoFinancial Analysis: Henry Schein (NASDAQ:HSIC) versus Owens & Minor (OMI)
www.americanbankingnews.com - July 21 at 10:23 PM
americanbankingnews.com logoJefferies Group LLC Reaffirms "Hold" Rating for Henry Schein, Inc. (HSIC)
www.americanbankingnews.com - July 21 at 8:56 AM
prnewswire.com logoHenry Schein Launches New Medical Website - PR Newswire (press release)
www.prnewswire.com - July 20 at 8:21 PM
americanbankingnews.com logo$3.04 Billion in Sales Expected for Henry Schein, Inc. (NASDAQ:HSIC) This Quarter
www.americanbankingnews.com - July 15 at 8:36 AM
finance.yahoo.com logoETFs with exposure to Henry Schein, Inc. : July 14, 2017
finance.yahoo.com - July 15 at 12:54 AM
americanbankingnews.com logoZacks: Analysts Anticipate Henry Schein, Inc. (HSIC) to Post $1.73 EPS
www.americanbankingnews.com - July 13 at 12:27 PM
finance.yahoo.com logoHenry Schein, Inc. – Value Analysis (NASDAQ:HSIC) : July 10, 2017
finance.yahoo.com - July 10 at 7:33 PM
prnewswire.com logoHenry Schein Oral Health Navigator Program Provides Oral Health Treatment For More Than 200 Children Fighting ... - PR Newswire (press release)
www.prnewswire.com - July 8 at 11:29 AM
finance.yahoo.com logoHenry Schein, Inc. breached its 50 day moving average in a Bearish Manner : HSIC-US : July 7, 2017
finance.yahoo.com - July 8 at 11:29 AM
finance.yahoo.com logoHenry Schein Oral Health Navigator Program Provides Oral Health Treatment For More Than 200 Children Fighting Cancer
finance.yahoo.com - July 7 at 6:13 AM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) Earns "Hold" Rating from Stifel Nicolaus
www.americanbankingnews.com - July 6 at 9:36 PM
finance.yahoo.com logoHenry Schein Supports Volunteer Endodontists Expanding Oral Health Care In Jamaica
finance.yahoo.com - July 5 at 8:13 PM
americanbankingnews.com logoComparing Cantel Medical Corp. (CMD) & Henry Schein (NASDAQ:HSIC)
www.americanbankingnews.com - July 5 at 2:12 PM
prnewswire.com logoHenry Schein Supports Volunteer Endodontists Expanding Oral Health Care In Jamaica - PR Newswire (press release)
www.prnewswire.com - July 5 at 8:06 AM
americanbankingnews.com logoHenry Schein, Inc. (NASDAQ:HSIC) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - July 3 at 9:14 AM
streetinsider.com logoHenry Schein (HSIC) Extends Agreement With DENTSPLY SIRONA in Canada
www.streetinsider.com - June 29 at 11:55 PM
finance.yahoo.com logoKeep Your Pets Safe From The Summer Heat With Infographic From Henry Schein Animal Health
finance.yahoo.com - June 29 at 11:55 PM
streetinsider.com logoHenry Schein (HSIC) Extends Agreement With DENTSPLY SIRONA ... - StreetInsider.com
www.streetinsider.com - June 28 at 7:07 PM
americanbankingnews.com logoCritical Survey: Henry Schein (HSIC) vs. Patterson Companies (PDCO)
www.americanbankingnews.com - June 28 at 8:36 AM
prnewswire.com logoHenry Schein Settles Litigation - PR Newswire (press release)
www.prnewswire.com - June 27 at 10:56 PM
streetinsider.com logoHenry Schein (HSIC) Settles Litigation with SourceOne Dental - StreetInsider.com
www.streetinsider.com - June 27 at 5:56 PM
finance.yahoo.com logoHenry Schein Settles Litigation
finance.yahoo.com - June 27 at 5:56 PM
americanbankingnews.com logoFinancial Survey: Merit Medical Systems (MMSI) and Henry Schein (HSIC)
www.americanbankingnews.com - June 25 at 4:06 PM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - June 23 at 12:50 PM
nasdaq.com logoHere's Why Henry Schein is Worth Adding to Your Portfolio
www.nasdaq.com - June 22 at 1:27 PM
americanbankingnews.com logoQ1 2018 EPS Estimates for Henry Schein, Inc. (HSIC) Lifted by Analyst
www.americanbankingnews.com - June 22 at 11:50 AM
americanbankingnews.com logo$3.04 Billion in Sales Expected for Henry Schein, Inc. (HSIC) This Quarter
www.americanbankingnews.com - June 21 at 10:45 AM
prnewswire.com logoHenry Schein Celebrates 20th Anniversary Of Sullivan Dental Merger - PR Newswire (press release)
www.prnewswire.com - June 19 at 4:42 PM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) Expected to Post Earnings of $1.73 Per Share
www.americanbankingnews.com - June 19 at 12:46 PM
finance.yahoo.com logoHenry Schein Celebrates 20th Anniversary Of Sullivan Dental Merger
finance.yahoo.com - June 19 at 12:34 PM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) Upgraded by Zacks Investment Research to Buy
www.americanbankingnews.com - June 16 at 1:12 PM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) Downgraded by Zacks Investment Research
www.americanbankingnews.com - June 15 at 9:48 AM
prnewswire.com logoDaily Technical Summary Reports on Services Stocks -- Booz Allen Hamilton ...
www.prnewswire.com - June 14 at 11:36 AM
prnewswire.com logoHenry Schein Supports Mobile Dental Hospital To Treat Kenyan Refugee Camp Residents - PR Newswire (press release)
www.prnewswire.com - June 13 at 8:18 AM
nasdaq.com logoHenry Schein (HSIC) Up 5.3% Since Earnings Report: Can It Continue? - Nasdaq
www.nasdaq.com - June 13 at 8:18 AM
finance.yahoo.com logoHenry Schein (HSIC) Up 5.3% Since Earnings Report: Can It Continue?
finance.yahoo.com - June 13 at 8:18 AM
finance.yahoo.com logoHenry Schein Supports Mobile Dental Hospital To Treat Kenyan Refugee Camp Residents
finance.yahoo.com - June 13 at 8:18 AM
prnewswire.com logoHenry Schein Awards Henry Schein Cares Gold Medal To Community Dental Care For Excellence In Expanding ... - PR Newswire (press release)
www.prnewswire.com - June 12 at 8:38 PM
finance.yahoo.com logoHenry Schein Awards Henry Schein Cares Gold Medal To Community Dental Care For Excellence In Expanding Access To Care
finance.yahoo.com - June 12 at 3:33 PM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) Receives New Coverage from Analysts at Piper Jaffray Companies
www.americanbankingnews.com - June 12 at 9:19 AM
americanbankingnews.com logoFY2017 Earnings Estimate for Henry Schein, Inc. Issued By Leerink Swann (HSIC)
www.americanbankingnews.com - June 12 at 7:44 AM
americanbankingnews.com logoHead to Head Review: Prestige Brands Holdings (PBH) and Henry Schein (HSIC)
www.americanbankingnews.com - June 11 at 2:22 PM
bizjournals.com logoCerner's VA deal is 'one of the largest health IT transactions ever'
www.bizjournals.com - June 7 at 5:19 PM
finance.yahoo.com logoHenry Schein Climbs To #243 On The Fortune 500®
finance.yahoo.com - June 7 at 5:19 PM
americanbankingnews.com logoHenry Schein, Inc. (HSIC) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - June 6 at 9:02 AM
americanbankingnews.com logoFinancial Analysis: Prestige Brands Holdings (PBH) & Henry Schein (HSIC)
www.americanbankingnews.com - June 5 at 2:20 PM
finance.yahoo.com logoETFs with exposure to Henry Schein, Inc. : May 29, 2017
finance.yahoo.com - May 29 at 5:31 PM

Social

Chart

Henry Schein (HSIC) Chart for Wednesday, July, 26, 2017

This page was last updated on 7/26/2017 by MarketBeat.com Staff